{"id":"W3029873699","doi":"10.1021/acschemneuro.0c00176","title":"Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases","year":2020,"lang":"en","type":"review","venue":"ACS Chemical Neuroscience","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Institute on Aging; Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Pharmaceuticals Bayer; Merck Sharp and Dohme; Genentech; National Institutes of Health; Novartis Pharma; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; ALS Association; Wellcome Trust; Fundação de Amparo à Pesquisa do Estado de São Paulo; Genome Canada; AbbVie; Takeda Pharmaceutical Company; Janssen Pharmaceuticals; Merck KGaA; Innovative Medicines Initiative; Wellcome; National Institute of Diabetes and Digestive and Kidney Diseases; Boehringer Ingelheim; Pfizer","keywords":"Kinome; Drug discovery; Kinase; Amyotrophic lateral sclerosis; Neuroscience; Disease; Drug development; Small molecule; Drug; Computational biology; Neurodegeneration; Medicine; Biology; Bioinformatics; Pharmacology; Cell biology; Biochemistry; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007502321,0.0006448098,0.001250021,0.0001034552,0.0002698574,0.0006548444,0.0005094828,0.00007448397,0.000001971504],"category_scores_gemma":[0.0009124358,0.0004114361,0.0003908639,0.0003956632,0.0004886903,0.0004130524,0.0004424467,0.0004021221,0.000001984735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002835855,"about_ca_system_score_gemma":0.0007466805,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002689318,"about_ca_topic_score_gemma":5.85718e-7,"domain_scores_codex":[0.9972652,0.0001663268,0.0005325051,0.001195941,0.0003464132,0.0004936269],"domain_scores_gemma":[0.9980031,0.0006534308,0.0001984519,0.0004664981,0.00009974444,0.0005788361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001538972,0.001972263,0.0001240357,0.04861445,0.0003384846,0.007169292,0.001880445,0.000215742,0.08313321,0.02820201,0.02173411,0.805077],"study_design_scores_gemma":[0.0007995219,0.0006134913,0.00005147378,0.002420755,0.001998081,0.0006344081,0.0003740504,0.0007421864,0.0102881,0.00007502796,0.9806474,0.001355549],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0263084,0.9676904,0.0001760953,0.002787342,0.0003012682,0.001762086,0.000839646,0.00009322706,0.00004152333],"genre_scores_gemma":[0.01342011,0.9682143,0.0001570662,0.01613992,0.0005215799,0.0007304599,0.000309749,0.000124031,0.0003827445],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9589133,"threshold_uncertainty_score":0.9998338,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09374240231430611,"score_gpt":0.3378624169568213,"score_spread":0.2441200146425152,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}